Published in Trends Endocrinol Metab on May 04, 2013
Homeostasis, inflammation, and disease susceptibility. Cell (2015) 1.41
O-GlcNAc and the epigenetic regulation of gene expression. J Biol Chem (2014) 1.27
Glucose regulates mitochondrial motility via Milton modification by O-GlcNAc transferase. Cell (2014) 1.21
O-GlcNAc transferase enables AgRP neurons to suppress browning of white fat. Cell (2014) 1.18
O-GlcNAcylation: A New Cancer Hallmark? Front Endocrinol (Lausanne) (2013) 1.16
Regulation of transcription factor activity by interconnected post-translational modifications. Trends Pharmacol Sci (2013) 0.95
Transcriptional coregulators: fine-tuning metabolism. Cell Metab (2014) 0.93
O-GlcNAcylation at promoters, nutrient sensors, and transcriptional regulation. Biochim Biophys Acta (2013) 0.91
O-GlcNAcylation and Metabolic Reprograming in Cancer. Front Endocrinol (Lausanne) (2014) 0.91
Regulation of protein degradation by O-GlcNAcylation: crosstalk with ubiquitination. Mol Cell Proteomics (2013) 0.90
O-GlcNAcase: promiscuous hexosaminidase or key regulator of O-GlcNAc signaling? J Biol Chem (2014) 0.89
Chromosome imbalance as a driver of sex disparity in disease. J Genomics (2014) 0.88
A critical perspective of the diverse roles of O-GlcNAc transferase in chromatin. Chromosoma (2015) 0.85
Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis? Carcinogenesis (2015) 0.85
O-GlcNAc signaling in cancer metabolism and epigenetics. Cancer Lett (2014) 0.84
Undetectable histone O-GlcNAcylation in mammalian cells. Epigenetics (2015) 0.82
Regulation of cancer metabolism by O-GlcNAcylation. Glycoconj J (2013) 0.82
Integrated microRNA and mRNA responses to acute human left ventricular ischemia. Physiol Genomics (2015) 0.81
Diabetes Induces Aberrant DNA Methylation in the Proximal Tubules of the Kidney. J Am Soc Nephrol (2015) 0.81
Dynamic O-linked N-acetylglucosamine modification of proteins affects stress responses and survival of mesothelial cells exposed to peritoneal dialysis fluids. J Am Soc Nephrol (2014) 0.80
Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity. J Lipid Res (2015) 0.80
Glycerol-3-phosphate acyltransferase-1 upregulation by O-GlcNAcylation of Sp1 protects against hypoxia-induced mouse embryonic stem cell apoptosis via mTOR activation. Cell Death Dis (2016) 0.79
Recognition of diazirine-modified O-GlcNAc by human O-GlcNAcase. Medchemcomm (2014) 0.79
O-GlcNAc: A Bittersweet Switch in Liver. Front Endocrinol (Lausanne) (2014) 0.79
In vivo and in vitro evidence that chronic activation of the hexosamine biosynthetic pathway interferes with leptin-dependent STAT3 phosphorylation. Am J Physiol Regul Integr Comp Physiol (2015) 0.78
Protein O-GlcNAcylation: emerging mechanisms and functions. Nat Rev Mol Cell Biol (2017) 0.78
O-GlcNAc Transferase is Essential for Sensory Neuron Survival and Maintenance. J Neurosci (2017) 0.77
Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB. Sci Rep (2016) 0.77
O-GlcNAcylation regulates ischemia-induced neuronal apoptosis through AKT signaling. Sci Rep (2015) 0.77
O-linked N-acetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes. Oncotarget (2016) 0.76
Neuronal Control of Adaptive Thermogenesis. Front Endocrinol (Lausanne) (2015) 0.76
Human RNA Polymerase II Promoter Recruitment in Vitro Is Regulated by O-Linked N-Acetylglucosaminyltransferase (OGT). J Biol Chem (2016) 0.76
The Translational Repressor 4E-BP1 Contributes to Diabetes-Induced Visual Dysfunction. Invest Ophthalmol Vis Sci (2016) 0.76
Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins. Biochem J (2016) 0.75
Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling. Oncotarget (2016) 0.75
Chromatin Dynamics of Circadian Transcription. Curr Mol Biol Rep (2015) 0.75
O-GlcNAcylation: a bridge between glucose and cell differentiation. J Cell Mol Med (2016) 0.75
Myeloid-derived cullin 3 promotes STAT3 phosphorylation by inhibiting OGT expression and protects against intestinal inflammation. J Exp Med (2017) 0.75
Proteomic approaches for site-specific O-GlcNAcylation analysis. Bioanalysis (2014) 0.75
The placenta and neurodevelopment: sex differences in prenatal vulnerability. Dialogues Clin Neurosci (2016) 0.75
WGA-based lectin affinity gel electrophoresis: A novel method for the detection of O-GlcNAc-modified proteins. PLoS One (2017) 0.75
Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease. J Pathol (2017) 0.75
Mutations in N-acetylglucosamine (O-GlcNAc) transferase in patients with X-linked intellectual disability. J Biol Chem (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell (2006) 11.85
Protein tyrosine phosphatases in the human genome. Cell (2004) 8.09
Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol (2011) 7.07
The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol (2010) 6.63
The meter of metabolism. Cell (2008) 5.71
Nuclear receptor expression links the circadian clock to metabolism. Cell (2006) 5.43
Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem (1984) 5.14
Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem (2011) 4.95
Central and peripheral circadian clocks in mammals. Annu Rev Neurosci (2012) 4.73
Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature (2007) 4.54
The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci STKE (2005) 4.20
Hepatic glucose sensing via the CREB coactivator CRTC2. Science (2008) 4.05
Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature (2008) 3.98
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat Cell Biol (2011) 3.70
Social jetlag and obesity. Curr Biol (2012) 3.37
Crosstalk between components of circadian and metabolic cycles in mammals. Cell Metab (2011) 3.31
A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell (2009) 3.27
O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J Biol Chem (1997) 3.16
Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med (2012) 3.08
Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A (2002) 3.08
Phosphofructokinase 1 glycosylation regulates cell growth and metabolism. Science (2012) 3.05
Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene (2010) 3.04
Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol (2006) 2.90
Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression. Cell (2002) 2.89
p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nat Cell Biol (2008) 2.81
Genetics of circadian rhythms in Mammalian model organisms. Adv Genet (2011) 2.80
Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat Rev Mol Cell Biol (2012) 2.74
Loss of the tumor suppressor BAP1 causes myeloid transformation. Science (2012) 2.69
Modeling of a human circadian mutation yields insights into clock regulation by PER2. Cell (2007) 2.63
Circadian topology of metabolism. Nature (2012) 2.63
O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta (2004) 2.62
O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell (2003) 2.51
c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem (1995) 2.47
O-GlcNAc transferase catalyzes site-specific proteolysis of HCF-1. Cell (2011) 2.45
Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab (2008) 2.40
Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci U S A (2002) 2.32
Emerging roles of nuclear protein phosphatases. Nat Rev Mol Cell Biol (2007) 2.28
GlcNAcylation of histone H2B facilitates its monoubiquitination. Nature (2011) 2.14
Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation (2008) 2.11
Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity. J Biol Chem (2000) 2.05
O-GlcNAc signaling: a metabolic link between diabetes and cancer? Trends Biochem Sci (2010) 2.05
The circadian clock interacts with metabolic physiology to influence reproductive fitness. Cell Metab (2011) 1.96
Identification of small molecule activators of cryptochrome. Science (2012) 1.95
A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout. Proc Natl Acad Sci U S A (2005) 1.93
Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation. Mol Cell Proteomics (2007) 1.92
Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest (1996) 1.72
Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes. J Biol Chem (1999) 1.72
Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance. Endocrinology (2003) 1.63
Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J Biol Chem (2012) 1.63
Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. J Biol Chem (2008) 1.62
Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase. J Cell Sci (2003) 1.62
O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci U S A (2001) 1.60
NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc Natl Acad Sci U S A (2008) 1.53
O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. Biochim Biophys Acta (2011) 1.52
Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Proc Natl Acad Sci U S A (2006) 1.51
Glucose regulation of insulin gene expression in pancreatic beta-cells. Biochem J (2008) 1.50
Exploring leukocyte O-GlcNAcylation as a novel diagnostic tool for the earlier detection of type 2 diabetes mellitus. J Clin Endocrinol Metab (2012) 1.49
Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene. Arch Biochem Biophys (2003) 1.49
Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification. Proc Natl Acad Sci U S A (2009) 1.48
O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability. Cell Metab (2012) 1.46
Regulation of the O-linked beta-N-acetylglucosamine transferase by insulin signaling. J Biol Chem (2008) 1.45
Insulin resistance of glycogen synthase mediated by o-linked N-acetylglucosamine. J Biol Chem (2003) 1.42
Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death. Proc Natl Acad Sci U S A (2000) 1.39
O-GlcNAcylation, novel post-translational modification linking myocardial metabolism and cardiomyocyte circadian clock. J Biol Chem (2011) 1.36
Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition. J Mol Cell Cardiol (2008) 1.36
The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells. Arch Biochem Biophys (2003) 1.33
O-linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function. Circ Res (2008) 1.32
Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle. Diabetes (2004) 1.29
Elevation of global O-GlcNAc levels in 3T3-L1 adipocytes by selective inhibition of O-GlcNAcase does not induce insulin resistance. J Biol Chem (2008) 1.28
Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes. J Biol Chem (2009) 1.28
O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes (2011) 1.28
Glucose mediates the translocation of NeuroD1 by O-linked glycosylation. J Biol Chem (2007) 1.25
O-GlcNAc protein modification in plants: Evolution and function. Biochim Biophys Acta (2009) 1.23
A role for O-GlcNAcylation in setting circadian clock speed. Genes Dev (2012) 1.21
Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab (2006) 1.20
Coordinated regulation of glutamine:fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. Role of hexosamine biosynthesis in enzyme regulation. J Biol Chem (1991) 1.20
Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. Glycobiology (2006) 1.20
Elevated O-linked N-acetylglucosamine metabolism in pancreatic beta-cells. Arch Biochem Biophys (1999) 1.18
Glucose sensor O-GlcNAcylation coordinates with phosphorylation to regulate circadian clock. Cell Metab (2013) 1.16
Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function. J Mol Cell Cardiol (2011) 1.14
O-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1/CLOCK ubiquitination. Cell Metab (2013) 1.14
O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation. Med Oncol (2011) 1.13
O-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs. Mol Cell Proteomics (2009) 1.13
Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia. Leukemia (2010) 1.11
Protein kinase Czeta mediates insulin-induced glucose transport through actin remodeling in L6 muscle cells. Mol Biol Cell (2006) 1.10
Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes (2000) 1.10
Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-β-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes. J Biol Chem (2012) 1.07
O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells. Exp Cell Res (2008) 1.07
O-GlcNAc modification and the tauopathies: insights from chemical biology. Curr Alzheimer Res (2009) 1.04
Human O-GlcNAc transferase (OGT): genomic structure, analysis of splice variants, fine mapping in Xq13.1. Mamm Genome (2002) 1.03
Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling. PLoS One (2012) 1.03
Increased expression of beta-N-acetylglucosaminidase in erythrocytes from individuals with pre-diabetes and diabetes. Diabetes (2010) 1.01
Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose. J Biol Chem (2009) 0.98
Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance. Diabetes (2000) 0.97
Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes. Mol Cell Endocrinol (2009) 0.96
Non-transcriptional oscillators in circadian timekeeping. Trends Biochem Sci (2012) 0.96
Altered O-GlcNAc modification and phosphorylation of mitochondrial proteins in myoblast cells exposed to high glucose. Arch Biochem Biophys (2010) 0.96
Enhanced cardiac protein glycosylation (O-GlcNAc) of selected mitochondrial proteins in rats artificially selected for low running capacity. Physiol Genomics (2012) 0.96
Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues. Endocrinology (1997) 0.95
Widespread transcription at neuronal activity-regulated enhancers. Nature (2010) 16.52
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors. Neuron (2006) 5.48
Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet (2010) 4.65
Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet (2009) 3.65
Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science (2013) 3.54
GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc Natl Acad Sci U S A (2003) 3.32
Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity. Nat Med (2011) 3.09
Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst (2013) 2.76
The Drosophila SDE3 homolog armitage is required for oskar mRNA silencing and embryonic axis specification. Cell (2004) 2.59
The IRE1alpha-XBP1 pathway of the unfolded protein response is required for adipogenesis. Cell Metab (2009) 2.52
O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell (2003) 2.51
China's health system performance. Lancet (2008) 2.36
Phase studies of model biomembranes: complex behavior of DSPC/DOPC/cholesterol. Biochim Biophys Acta (2007) 2.22
Resting-state functional connectivity of subgenual anterior cingulate cortex in depressed adolescents. Biol Psychiatry (2013) 2.07
A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nat Genet (2011) 2.05
Klotho is a target gene of PPAR-gamma. Kidney Int (2008) 1.96
Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J Clin Invest (2015) 1.89
Comparison of three ternary lipid bilayer mixtures: FRET and ESR reveal nanodomains. Biophys J (2010) 1.88
Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation. Methods Mol Biol (2004) 1.85
Escherichia coli noncoding RNAs can affect gene expression and physiology of Caenorhabditis elegans. Nat Commun (2012) 1.78
Adolescents with major depression demonstrate increased amygdala activation. J Am Acad Child Adolesc Psychiatry (2010) 1.69
Effect of limb ischemic preconditioning on myocardial injury in patients undergoing mitral valve replacement surgery. -A randomized controlled trial-. Circ J (2011) 1.62
Phase studies of model biomembranes: macroscopic coexistence of Lalpha+Lbeta, with light-induced coexistence of Lalpha+Lo Phases. Biochim Biophys Acta (2007) 1.61
DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest (2014) 1.59
Effect of celecoxib on E-cadherin, VEGF, Microvessel density and apoptosis in gastric cancer. Cancer Biol Ther (2007) 1.59
Immune activation caused by vascular oxidation promotes fibrosis and hypertension. J Clin Invest (2015) 1.55
Calcium-calmodulin-dependent protein kinase II contributes to spinal cord central sensitization. J Neurosci (2002) 1.51
Activity-induced Notch signaling in neurons requires Arc/Arg3.1 and is essential for synaptic plasticity in hippocampal networks. Neuron (2011) 1.49
O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability. Cell Metab (2012) 1.46
Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. J Clin Invest (2007) 1.45
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. J Neurooncol (2012) 1.42
Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. Glycobiology (2006) 1.41
LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proc Natl Acad Sci U S A (2010) 1.40
gamma-Cyclodextrin: a review on enzymatic production and applications. Appl Microbiol Biotechnol (2007) 1.39
GUV preparation and imaging: minimizing artifacts. Biochim Biophys Acta (2010) 1.39
The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Mol Cell (2012) 1.39
The effects of midday nap duration on the risk of hypertension in a middle-aged and older Chinese population: a preliminary evidence from the Tongji-Dongfeng Cohort Study, China. J Hypertens (2014) 1.39
Application of multivariate statistical techniques in the assessment of water quality in the Southwest New Territories and Kowloon, Hong Kong. Environ Monit Assess (2010) 1.34
Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis. PLoS One (2012) 1.29
Control of a nanoscopic-to-macroscopic transition: modulated phases in four-component DSPC/DOPC/POPC/Chol giant unilamellar vesicles. Biophys J (2011) 1.28
REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS One (2009) 1.28
O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes (2011) 1.28
Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells. J Biol Chem (2008) 1.26
Amygdala response and functional connectivity during emotion regulation: a study of 14 depressed adolescents. J Affect Disord (2012) 1.24
Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells. PLoS One (2011) 1.22
Liquid-liquid domains in bilayers detected by wide angle X-ray scattering. Biophys J (2008) 1.21
Alterations of metabolic genes and metabolites in cancer. Semin Cell Dev Biol (2012) 1.18
Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics. PLoS One (2008) 1.18
Toward an understanding of the molecular mechanism for successful blood feeding by coupling proteomics analysis with pharmacological testing of horsefly salivary glands. Mol Cell Proteomics (2007) 1.17
Evaluation of Kato-Katz examination method in three areas with low-level endemicity of schistosomiasis japonica in China: A Bayesian modeling approach. Acta Trop (2009) 1.17
Comparison of methods for fecal microbiome biospecimen collection. BMC Microbiol (2014) 1.17
Anti-infection peptidomics of amphibian skin. Mol Cell Proteomics (2007) 1.16
Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model. Cancer Res (2002) 1.16
Molecular characterization of the genome of duck enteritis virus. Virology (2009) 1.15
O-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1/CLOCK ubiquitination. Cell Metab (2013) 1.14
Identification and characterization of bacterial cutinase. J Biol Chem (2008) 1.13
Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection. Foodborne Pathog Dis (2010) 1.13
Disappearance of the telomere dysfunction-induced stress response in fully senescent cells. Cancer Res (2004) 1.12
Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease. Mol Cell Proteomics (2013) 1.11
Adhesion stabilizes robust lipid heterogeneity in supercritical membranes at physiological temperature. Biophys J (2013) 1.11
Depressed adolescents demonstrate greater subgenual anterior cingulate activity. Neuroreport (2009) 1.10
New method for determining tie-lines in coexisting membrane phases using spin-label ESR. Biochim Biophys Acta (2005) 1.10
Regulation of transcription factor NFAT by ADP-ribosylation. Mol Cell Biol (2008) 1.09
Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma. Mol Cell Proteomics (2013) 1.09
Cutinase-like proteins of Mycobacterium tuberculosis: characterization of their variable enzymatic functions and active site identification. FASEB J (2009) 1.07
Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg. Eur J Immunol (2010) 1.07
A phosphomimetic mutation at threonine-57 abolishes transactivation activity and alters nuclear localization pattern of human pregnane x receptor. Drug Metab Dispos (2009) 1.07
The in vivo synaptic plasticity mechanism of EGb 761-induced enhancement of spatial learning and memory in aged rats. Br J Pharmacol (2006) 1.06
Expression of wild soybean WRKY20 in Arabidopsis enhances drought tolerance and regulates ABA signalling. J Exp Bot (2013) 1.06
Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice. Diabetes (2007) 1.06
Platelet fragmentation requires a specific structural conformation of human monoclonal antibody against beta3 integrin. J Biol Chem (2007) 1.05
Vascular binding of a pathogen under shear force through mechanistically distinct sequential interactions with host macromolecules. Mol Microbiol (2012) 1.05
Toxicology and drug delivery by cucurbit[n]uril type molecular containers. PLoS One (2010) 1.05
Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies. J Proteome Res (2014) 1.05
Infant feeding practices in Xinjiang Uygur Autonomous Region, People's Republic of China. Public Health Nutr (2007) 1.04
Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. J Proteome Res (2014) 1.04
Novel compound heterozygous TMC1 mutations associated with autosomal recessive hearing loss in a Chinese family. PLoS One (2013) 1.04
The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients. Br J Clin Pharmacol (2008) 1.04
A role for lymphotoxin in primary Sjogren's disease. J Immunol (2010) 1.03
Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS. J Proteome Res (2013) 1.03
Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR-dependent motility in alveolar rhabdomyosarcoma cells. BMC Cancer (2012) 1.03
Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models. PLoS One (2013) 1.02
Proteolysis of Rad17 by Cdh1/APC regulates checkpoint termination and recovery from genotoxic stress. EMBO J (2010) 1.02
Role of transcription factor NFAT in glucose and insulin homeostasis. Mol Cell Biol (2006) 1.02
Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma. J Neurooncol (2007) 1.02
Population structure of the malaria vector Anopheles sinensis (Diptera: Culicidae) in China: two gene pools inferred by microsatellites. PLoS One (2011) 1.02
Genetic variants in the folate pathway and the risk of neural tube defects: a meta-analysis of the published literature. PLoS One (2013) 1.01
Extracellular expression and biochemical characterization of alpha-cyclodextrin glycosyltransferase from Paenibacillus macerans. Carbohydr Res (2010) 1.01
Tumefactive demyelinating lesions: nine cases and a review of the literature. Neurosurg Rev (2009) 1.00
Altered cerebral perfusion in executive, affective, and motor networks during adolescent depression. J Am Acad Child Adolesc Psychiatry (2013) 0.99
Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer (2010) 0.99
The first gene-encoded amphibian neurotoxin. J Biol Chem (2009) 0.99
Sulfur hexafluoride (SF6) emission estimates for China: an inventory for 1990-2010 and a projection to 2020. Environ Sci Technol (2013) 0.98
A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer. Breast Cancer Res Treat (2010) 0.98